UAE has granted approval for final testing of a Covid-19 vaccine developed by Chinese company. A vaccine developed by China government owned China National Biotec Group Company has got approval from UAE.
It was granted approval to conduct Phase III trials for its Covid-19 vaccines in the UAE.The Chinese company will partner with Abu Dhabi-based artificial intelligence and cloud computing firm G42 to carry out the trial and local production of the vaccine.
Chinese biotech CanSino Biologics Inc. was approved last month to conduct human testing for the vaccine it co-developed with the Chinese military in Canada, but will need to re-do early safety studies before going into the Phase III trial. Beijing-based Sinovac Biotech Ltd. has partnered with Instituto Butantan to roll out testing of its shot on 9,000 people in the hot spot of Brazil, but has not yet won approval to proceed.
Vaccine candidates from companies outside of China are also headed for Phase III trials. A shot co-developed by the University of Oxford and AstraZeneca Plc will be tested among 2,000 people in Brazil starting as early as this month. Cambridge, Massachusetts-based Moderna Inc. is set to begin testing its shot next month in a 30,000-person trial in the US. The two shots developed by CNBG have already been tested among some 2,000 people in phase I and II trials conducted in China.
Post Your Comments